Market Cap 2.62B
Revenue (ttm) 70.85M
Net Income (ttm) -342.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -483.56%
Debt to Equity Ratio 0.00
Volume 1,992,400
Avg Vol 2,103,152
Day's Range N/A - N/A
Shares Out 113.29M
Stochastic %K 99%
Beta 0.91
Analysts Strong Sell
Price Target $36.69

Company Profile

Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered, and Elegrobart, a low-volume, infrequently dosed subcutaneous IGF-1R. The company also develops an anti-thyroid-stimulating hormone receptor (TSHR) candidate for the treatment of Graves' disease...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 272 4600
Fax: 617 272 4601
Address:
221 Crescent Street, Suite 103A, Waltham, United States
schmittzi
schmittzi Aug. 19 at 10:57 AM
0 · Reply
Gemini367
Gemini367 Aug. 19 at 8:52 AM
$VRDN looking better and better. However, we have to breakt $24. Good luck.
0 · Reply
CDMO
CDMO Aug. 18 at 8:28 PM
$IDYA $VRDN very strong today
1 · Reply
kizildag_
kizildag_ Aug. 18 at 3:57 PM
$VRDN It's still very cheap. I haven't seen such an asymmetric return opportunity in a long time. Buy it and forget about it. Focus on your life. This is over.
1 · Reply
Tdorsey1776
Tdorsey1776 Aug. 17 at 11:19 PM
$VRDN Better than Tepezza
0 · Reply
Tdorsey1776
Tdorsey1776 Aug. 17 at 5:06 PM
$VRDN 9mm shares short....well underwater now. Squuuuueeeeeeeeeeze
1 · Reply
Tdorsey1776
Tdorsey1776 Aug. 17 at 5:04 PM
$VRDN Viridian and $CADL for the win
0 · Reply
Pika_Capital
Pika_Capital Aug. 17 at 3:00 PM
$VRDN +70% from recent lows. If you sold you should not be investing in biotech 🤡
1 · Reply
Biotechinves
Biotechinves Aug. 12 at 12:44 PM
0 · Reply
TheProphitWhisperer
TheProphitWhisperer Aug. 11 at 8:07 PM
$VRDN chart looking healthy to push to $30+
0 · Reply
Latest News on VRDN
Viridian Therapeutics reports EPS ($1.05), consensus ($1.03)

2026-08-06T11:36:38.000Z - 13 days ago

Viridian Therapeutics reports EPS ($1.05), consensus ($1.03)


Viridian Therapeutics sees cash runway through profitability

2026-08-06T11:36:23.000Z - 13 days ago

Viridian Therapeutics sees cash runway through profitability


Viridian Therapeutics Earnings release: Q2 2026

Aug 6, 2026, 7:00 AM EDT - 13 days ago

Viridian Therapeutics Earnings release: Q2 2026


Viridian Therapeutics Slides: Q2 2026

Aug 6, 2026, 7:00 AM EDT - 13 days ago

Viridian Therapeutics Slides: Q2 2026


Viridian Therapeutics Quarterly report: Q2 2026

Aug 6, 2026, 7:00 AM EDT - 13 days ago

Viridian Therapeutics Quarterly report: Q2 2026


Viridian Therapeutics Transcript: FDA announcement

Jun 29, 2026, 8:00 AM EDT - 7 weeks ago

Viridian Therapeutics Transcript: FDA announcement


Viridian Therapeutics Press release: FDA announcement

Jun 29, 2026, 8:00 AM EDT - 7 weeks ago

Viridian Therapeutics Press release: FDA announcement


Viridian Therapeutics Slides: FDA announcement

Jun 29, 2026, 8:00 AM EDT - 7 weeks ago

Viridian Therapeutics Slides: FDA announcement


Viridian Therapeutics Slides: Company presentation

Jun 1, 2026, 8:00 AM EDT - 2 months ago

Viridian Therapeutics Slides: Company presentation


Viridian Therapeutics Slides: Corporate presentation

Jun 1, 2026, 7:00 AM EDT - 2 months ago

Viridian Therapeutics Slides: Corporate presentation


Viridian Therapeutics Transcript: Study result

May 5, 2026, 8:00 AM EDT - 3 months ago

Viridian Therapeutics Transcript: Study result


Viridian Therapeutics Press release: Study result

May 5, 2026, 8:00 AM EDT - 3 months ago

Viridian Therapeutics Press release: Study result


Viridian Therapeutics Slides: Study result

May 5, 2026, 8:00 AM EDT - 3 months ago

Viridian Therapeutics Slides: Study result


Viridian announces REVEAL-2 phase 3 study met primary endpoint

2026-05-05T11:38:18.000Z - 3 months ago

Viridian announces REVEAL-2 phase 3 study met primary endpoint


Viridian Therapeutics reports Q1 EPS (90c), consensus ($1.09)

2026-05-05T11:26:55.000Z - 3 months ago

Viridian Therapeutics reports Q1 EPS (90c), consensus ($1.09)


Viridian Therapeutics Quarterly report: Q1 2026

May 5, 2026, 7:00 AM EDT - 3 months ago

Viridian Therapeutics Quarterly report: Q1 2026


Viridian Therapeutics Earnings release: Q1 2026

May 5, 2026, 7:00 AM EDT - 3 months ago

Viridian Therapeutics Earnings release: Q1 2026


Viridian Therapeutics Slides: Corporate presentation

May 5, 2026, 7:00 AM EDT - 3 months ago

Viridian Therapeutics Slides: Corporate presentation


Viridian Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 4 months ago

Viridian Therapeutics Proxy statement: Proxy filing


Viridian Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 4 months ago

Viridian Therapeutics Proxy statement: Proxy filing


Viridian Therapeutics Transcript: Study result

Mar 30, 2026, 8:00 AM EDT - 5 months ago

Viridian Therapeutics Transcript: Study result


Viridian Therapeutics Press release: Study result

Mar 30, 2026, 8:00 AM EDT - 5 months ago

Viridian Therapeutics Press release: Study result


Viridian Therapeutics Slides: Study result

Mar 30, 2026, 8:00 AM EDT - 5 months ago

Viridian Therapeutics Slides: Study result


Viridian Therapeutics Slides: Corporate presentation

Mar 30, 2026, 7:00 AM EDT - 5 months ago

Viridian Therapeutics Slides: Corporate presentation


Viridian Therapeutics Annual report: Q4 2025

Feb 26, 2026, 7:00 AM EST - 6 months ago

Viridian Therapeutics Annual report: Q4 2025


Viridian Therapeutics Earnings release: Q4 2025

Feb 26, 2026, 7:00 AM EST - 6 months ago

Viridian Therapeutics Earnings release: Q4 2025


Viridian Therapeutics Slides: Corporate presentation

Feb 26, 2026, 6:00 AM EST - 6 months ago

Viridian Therapeutics Slides: Corporate presentation


Viridian Therapeutics Prepares for Transformational 2026

Jan 6, 2026, 7:01 AM EST - 8 months ago

Viridian Therapeutics Prepares for Transformational 2026


Viridian Therapeutics Slides: Corporate Presentation

Jan 6, 2026, 7:00 AM EST - 8 months ago

Viridian Therapeutics Slides: Corporate Presentation


Viridian Therapeutics Quarterly report: Q3 2025

Nov 5, 2025, 7:00 AM EST - 10 months ago

Viridian Therapeutics Quarterly report: Q3 2025


Viridian Therapeutics Earnings release: Q3 2025

Nov 5, 2025, 7:00 AM EST - 10 months ago

Viridian Therapeutics Earnings release: Q3 2025


Viridian Therapeutics Slides: Corporate Presentation

Nov 4, 2025, 6:00 PM EST - 10 months ago

Viridian Therapeutics Slides: Corporate Presentation


Viridian Therapeutics Earnings release: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Viridian Therapeutics Earnings release: Q2 2025


Viridian Therapeutics Quarterly report: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Viridian Therapeutics Quarterly report: Q2 2025


Viridian Therapeutics Slides: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Viridian Therapeutics Slides: Q2 2025


Viridian Therapeutics Slides: Corporate Presentation

Jun 5, 2025, 6:00 PM EDT - 1 year ago

Viridian Therapeutics Slides: Corporate Presentation


Viridian Therapeutics Quarterly report: Q1 2025

May 6, 2025, 7:00 AM EDT - 1 year ago

Viridian Therapeutics Quarterly report: Q1 2025


Viridian Therapeutics Earnings release: Q1 2025

May 6, 2025, 7:00 AM EDT - 1 year ago

Viridian Therapeutics Earnings release: Q1 2025


Viridian Therapeutics Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Viridian Therapeutics Proxy statement: Proxy Filing


Viridian Therapeutics Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Viridian Therapeutics Proxy statement: Proxy Filing


Viridian Therapeutics Annual report: Q4 2024

Feb 27, 2025, 7:00 AM EST - 1 year ago

Viridian Therapeutics Annual report: Q4 2024


Viridian Therapeutics Earnings release: Q4 2024

Feb 27, 2025, 7:00 AM EST - 1 year ago

Viridian Therapeutics Earnings release: Q4 2024


Viridian Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Viridian Therapeutics Earnings release: Q3 2024


Viridian Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Viridian Therapeutics Quarterly report: Q3 2024


Viridian Therapeutics Quarterly report: Q2 2024

Aug 8, 2024, 7:00 AM EDT - 2 years ago

Viridian Therapeutics Quarterly report: Q2 2024


Viridian Therapeutics Earnings release: Q2 2024

Aug 8, 2024, 7:00 AM EDT - 2 years ago

Viridian Therapeutics Earnings release: Q2 2024


Viridian Therapeutics Proxy statement: Proxy Filing

Jun 10, 2024, 8:00 AM EDT - 2 years ago

Viridian Therapeutics Proxy statement: Proxy Filing


Viridian Therapeutics Earnings Call Transcript: Q1 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

Viridian Therapeutics Earnings Call Transcript: Q1 2024


Viridian Therapeutics Quarterly report: Q1 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

Viridian Therapeutics Quarterly report: Q1 2024


Viridian Therapeutics Earnings release: Q1 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

Viridian Therapeutics Earnings release: Q1 2024


Viridian Therapeutics Slides: Q1 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

Viridian Therapeutics Slides: Q1 2024


schmittzi
schmittzi Aug. 19 at 10:57 AM
0 · Reply
Gemini367
Gemini367 Aug. 19 at 8:52 AM
$VRDN looking better and better. However, we have to breakt $24. Good luck.
0 · Reply
CDMO
CDMO Aug. 18 at 8:28 PM
$IDYA $VRDN very strong today
1 · Reply
kizildag_
kizildag_ Aug. 18 at 3:57 PM
$VRDN It's still very cheap. I haven't seen such an asymmetric return opportunity in a long time. Buy it and forget about it. Focus on your life. This is over.
1 · Reply
Tdorsey1776
Tdorsey1776 Aug. 17 at 11:19 PM
$VRDN Better than Tepezza
0 · Reply
Tdorsey1776
Tdorsey1776 Aug. 17 at 5:06 PM
$VRDN 9mm shares short....well underwater now. Squuuuueeeeeeeeeeze
1 · Reply
Tdorsey1776
Tdorsey1776 Aug. 17 at 5:04 PM
$VRDN Viridian and $CADL for the win
0 · Reply
Pika_Capital
Pika_Capital Aug. 17 at 3:00 PM
$VRDN +70% from recent lows. If you sold you should not be investing in biotech 🤡
1 · Reply
Biotechinves
Biotechinves Aug. 12 at 12:44 PM
0 · Reply
TheProphitWhisperer
TheProphitWhisperer Aug. 11 at 8:07 PM
$VRDN chart looking healthy to push to $30+
0 · Reply
Biotechinves
Biotechinves Aug. 11 at 2:12 PM
$VRDN good
0 · Reply
schmittzi
schmittzi Aug. 11 at 1:54 PM
0 · Reply
Biotechinves
Biotechinves Aug. 10 at 2:21 PM
0 · Reply
Jh900
Jh900 Aug. 7 at 7:06 PM
$VRDN it just doesn’t stop until 30
0 · Reply
4Reel
4Reel Aug. 7 at 3:52 PM
$VRDN notice what happened after it fi ally broke resistance. Running big....in the gap.
1 · Reply
DipinDipout
DipinDipout Aug. 6 at 7:53 PM
$VRDN cafépharma is the National Enquirer of the pharmaceutical, biotech industry, mostly complaining miserable people getting fired or that don’t work… Absolute trash, garbage complainers!
0 · Reply
VRDNBull
VRDNBull Aug. 6 at 7:14 PM
$VRDN Comments on Cafepharma's Amgen board seem to indicate that there aresome negative issues within the Tepezza sales force.
0 · Reply
Biotechinves
Biotechinves Aug. 6 at 6:57 PM
0 · Reply
kizildag_
kizildag_ Aug. 6 at 6:42 PM
$VRDN Yes, normally something like "This stock is very cheap because of this reason" should have been said. However, we are in such a situation that the market doesn't even believe in the potential or clinical superiority of TED. I want to appeal to anyone who has moved 19 million shorts as of July 15 , you are really heavy jerks, and just know that thanks to you, we will hit the jackpot.
0 · Reply
Tdorsey1776
Tdorsey1776 Aug. 6 at 5:25 PM
$VRDN Shocking to me that ~9mm shares were sold short between Aprill and July, all well underwater now. What are thinking?
1 · Reply
Tdorsey1776
Tdorsey1776 Aug. 6 at 5:23 PM
$VRDN Must be on M&A lists, still cheap here. Better than Tepezza. GLTA
0 · Reply
Grannynani
Grannynani Aug. 6 at 4:08 PM
$VRDN god damn👏🏼👏🏼👏🏼📈 that’s a play
0 · Reply